PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VIR vs. CRT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


VIRCRT
YTD Return-4.57%-40.29%
1Y Return17.94%-41.19%
3Y Return (Ann)-33.47%-2.22%
5Y Return (Ann)-7.05%13.76%
Sharpe Ratio0.19-1.05
Sortino Ratio0.84-1.59
Omega Ratio1.090.81
Calmar Ratio0.13-0.64
Martin Ratio0.49-1.24
Ulcer Index23.93%34.19%
Daily Std Dev60.95%40.17%
Max Drawdown-91.26%-83.46%
Current Drawdown-88.44%-62.26%

Fundamentals


VIRCRT
Market Cap$1.34B$59.16M
EPS-$3.87$1.28
Total Revenue (TTM)$78.62M$5.98M
Gross Profit (TTM)$64.40M$9.09M
EBITDA (TTM)-$499.25M$2.96M

Correlation

-0.50.00.51.00.0

The correlation between VIR and CRT is 0.01, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

VIR vs. CRT - Performance Comparison

In the year-to-date period, VIR achieves a -4.57% return, which is significantly higher than CRT's -40.29% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
1.69%
-25.65%
VIR
CRT

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VIR vs. CRT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Cross Timbers Royalty Trust (CRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VIR
Sharpe ratio
The chart of Sharpe ratio for VIR, currently valued at 0.19, compared to the broader market-4.00-2.000.002.004.000.19
Sortino ratio
The chart of Sortino ratio for VIR, currently valued at 0.84, compared to the broader market-4.00-2.000.002.004.006.000.84
Omega ratio
The chart of Omega ratio for VIR, currently valued at 1.09, compared to the broader market0.501.001.502.001.09
Calmar ratio
The chart of Calmar ratio for VIR, currently valued at 0.13, compared to the broader market0.002.004.006.000.13
Martin ratio
The chart of Martin ratio for VIR, currently valued at 0.49, compared to the broader market0.0010.0020.0030.000.49
CRT
Sharpe ratio
The chart of Sharpe ratio for CRT, currently valued at -1.05, compared to the broader market-4.00-2.000.002.004.00-1.05
Sortino ratio
The chart of Sortino ratio for CRT, currently valued at -1.59, compared to the broader market-4.00-2.000.002.004.006.00-1.59
Omega ratio
The chart of Omega ratio for CRT, currently valued at 0.81, compared to the broader market0.501.001.502.000.81
Calmar ratio
The chart of Calmar ratio for CRT, currently valued at -0.64, compared to the broader market0.002.004.006.00-0.64
Martin ratio
The chart of Martin ratio for CRT, currently valued at -1.24, compared to the broader market0.0010.0020.0030.00-1.24

VIR vs. CRT - Sharpe Ratio Comparison

The current VIR Sharpe Ratio is 0.19, which is higher than the CRT Sharpe Ratio of -1.05. The chart below compares the historical Sharpe Ratios of VIR and CRT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.00JuneJulyAugustSeptemberOctoberNovember
0.19
-1.05
VIR
CRT

Dividends

VIR vs. CRT - Dividend Comparison

VIR has not paid dividends to shareholders, while CRT's dividend yield for the trailing twelve months is around 10.99%.


TTM20232022202120202019201820172016201520142013
VIR
Vir Biotechnology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CRT
Cross Timbers Royalty Trust
10.99%10.97%7.69%9.70%9.44%10.05%13.08%6.86%5.90%10.41%15.33%7.88%

Drawdowns

VIR vs. CRT - Drawdown Comparison

The maximum VIR drawdown since its inception was -91.26%, which is greater than CRT's maximum drawdown of -83.46%. Use the drawdown chart below to compare losses from any high point for VIR and CRT. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%JuneJulyAugustSeptemberOctoberNovember
-88.44%
-62.26%
VIR
CRT

Volatility

VIR vs. CRT - Volatility Comparison

Vir Biotechnology, Inc. (VIR) has a higher volatility of 23.41% compared to Cross Timbers Royalty Trust (CRT) at 9.68%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than CRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
23.41%
9.68%
VIR
CRT

Financials

VIR vs. CRT - Financials Comparison

This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and Cross Timbers Royalty Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items